New Antimicrobial Agents

Barson, 1985, Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children, Pediatr Infect Dis J, 4, 362, 10.1097/00006454-198507000-00006 Birnbaum, 1985, Carbapenems: A new class of beta-lactam antibiotics, Am J Med, 78, 6A3, 10.1016/0002-9343(85)90097-X Buening, 1982, Ethanol-moxalactam interactions in vivo, Rev Infect Dis, 4S, 555, 10.1093/clinids/4.Supplement_3.S555 Centers for Disease Control and Prevention, 1994, Decreased susceptibility of N. gonorrhoeae to fluoroquinolones: Ohio and Hawaii, 1992-4, MMWR, 43, 325 Chang, 1988, In vitro effects of four macrolides on Toxoplasma gondii, Antimicrob Agents Chemother, 32, 524, 10.1128/AAC.32.4.524 Chartrand, 1981, Development of H. influenzae meningitis in patients treated with cefamandole, J Pediatr, 98, 1003, 10.1016/S0022-3476(81)80618-X Christ, 1988, Specific toxicologic aspects of the quinolones, Rev Infect Dis, 141, 10.1093/clinids/10.Supplement_1.S141 Dautzenberg, 1991, Activity of clarithromycin against M. avium infection in patients with the acquired immune deficiency syndrome, Am Rev Respir Dis, 144, 564, 10.1164/ajrccm/144.3_Pt_1.564 Douidar, 1989, Potential role of fluoroquinolones in pediatric infections, Rev Infect Dis, 11, 878, 10.1093/clinids/11.6.878 Eisenberg, 1994, Azithromycin and clarithromycin, Curr Clin Topics Infect Dis, 14, 52 Goldman, 1993, The role of azithromycin and clarithromycin in clinical practice, Cleveland Clinic J Med, 60, 359, 10.3949/ccjm.60.5.359 Gu, 1991, Comparative in vitro killing rates of cefotetan and ampicillin-sulbactam against Bacteroides and mixed cultures of Bacteroides plus E. coli and Klebsiella. Abstr 669 Handsfield, 1991, A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea, N Engl J Med, 325, 1337, 10.1056/NEJM199111073251903 Hardy, 1988, Comparative in vitro activities of new 14-, 15-, and 16 member macrolides, Antimicrob Agents Chemother, 32, 1710, 10.1128/AAC.32.11.1710 Heilmann, 1993, Ampicillin and ampicillin-sulbactam dilution tests with mixed cultures of B. fragilis, E. coli and Enterococcus, Infection, 21, 187, 10.1007/BF01710545 Heim-Duthoy, 1990, Apparent biliary pseudolithiasis during ceftriaxone therapy, Antimicrob Agents Chemother, 34, 1146, 10.1128/AAC.34.6.1146 Heizmann, 1990, Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections, Infection, 18, 117, 10.1007/BF01641431 Hihashitani, 1990, Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin, J Antimicrob Chemother, 25, 567, 10.1093/jac/25.4.567 Hiraoka, 1988, Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins, Rev Infect Dis, 10, 746, 10.1093/clinids/10.4.746 Hooper, 1991, Fluoroquinolone antimicrobial agents, N Engl J Med, 324, 384, 10.1056/NEJM199102073240606 Huber, 1993, Fluoroquinolones: Therapeutic advances in infectious diseases, Pharmacotherapy, 13, S1 Itokazu, 1991, Ampicillin-sulbactam and ticarcillin-clavulanic acid: A comparison of their in vitro activity and review of their clinical efficacy, Pharmacotherapy, 11, 382 Jones, 1988, Antimicrobial activity, spectrum and recommendations for disk diffusion susceptibility testing of ceftibuten, a new orally administered cephalosporin, Antimicrob Agents Chemother, 32, 1576, 10.1128/AAC.32.10.1576 Jorgensen, 1990, Antimicrobial resistance among respiratory isolates of H. influenzae, M. catarrhalis and St. pneumoniae in the United States, Antimicrob Agents Chemother, 34, 2075, 10.1128/AAC.34.11.2075 Kirst, 1989, New directions for macrolide antibiotics: structure modifications and in vitro activity, Antimicrob Agents Chemother, 33, 1413, 10.1128/AAC.33.9.1413 Levine, 1985, Quantitative comparison of adverse reactions to cefaclor in a surveillance study, Pediatr Infect Dis J, 4, 358, 10.1097/00006454-198507000-00005 Linares, 1992, Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics, J Antimicrob Chemother, 30, 279, 10.1093/jac/30.3.279 Maskell, 1990, Comparative in vitro activity of azithromycin and erythromycin against gram positive cocci, J Antimicrob Chemother, 25, SA19, 10.1093/jac/25.suppl_A.19 Mason, 1992, Increased rate of isolation of penicillin-resistant S. pneumoniae in a children’s hospital and in vitro susceptibilities to antibiotics of potential therapeutic use, Antimicrob Agents Chemother, 36, 1703, 10.1128/AAC.36.8.1703 The Medical Letter, 1992, Cefpodoxime proxetil: A new cephalosporin, 34, 107 The Medical Letter, 1992, Loracarbef, 34, 87 Neu, 1986, Beta-lactam antibiotics: Structural relationships affecting in vitro activity and pharmacologic properties, Rev Infect Dis, 8, 237, 10.1093/clinids/8.Supplement_3.S237 Neu, 1985, Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases, Am J Med, 79, 5B 2, 10.1016/0002-9343(85)90123-8 Neu, 1991, The development of macrolides: Clarithromycin in perspective, J Antimicrob Chemother, 27, 1, 10.1093/jac/27.suppl_A.1 Neu, 1987, In vitro activity of a new broad spectrum beta lactamase-stable oral cephalosporin, cefixime, Pediatr Infect Dis J, 6, 958, 10.1097/00006454-198710000-00034 Nikaido, 1990, Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents, Antimicrob Agents Chemother, 34, 337, 10.1128/AAC.34.2.337 Olsson-Liljequist, 1991, In vitro activity of clarithromycin combined with its 14 -OH metabolite against H. influenzae, J Antimicrob Chemother, 27, 11, 10.1093/jac/27.suppl_A.11 Pastel, 1986, Imipenem-cilastin sodium: A broad-spectrum carbapenem antibiotic combination, Clin Pharm, 5, 719 Peltola, 1989, Randomized comparison of chloramphenicol, ampicillin, cefotaxime and ceftriaxone for childhood bacterial meningitis, Lancet, 1, 1281, 10.1016/S0140-6736(89)92685-8 Potschafer, 1982, Cefaclor pharmacokinetic parameters: Serum concentrations determined by a new high performance liquid chromatographic technique, Antimicrob Agents Chemother, 21, 170, 10.1128/AAC.21.1.170 Sader, 1993, Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs, Eur J Clin Microbiol Infect Dis, 12, 384, 10.1007/BF01964439 Sanders, 1993, Cefepime: The next generation, Clin Infect Dis, 17, 369 Sanders, 1986, Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics, J Infect Dis, 154, 796, 10.1093/infdis/154.5.792 Schaad, 1987, Nalidixic acid in children: Retrospective matched controlled study for cartilage toxicity, Infection, 15, 165, 10.1007/BF01646040 Schaad, 1991, Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin, Pediatr Infect Dis J, 10, 723 Schaad, 1990, A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children, N Engl J Med, 322, 141, 10.1056/NEJM199001183220301 Scully, 1987, Ciprofloxacin therapy in cystic fibrosis, Am J Med, 196 Smith, 1983, Cefuroxime: Antimicrobial activity, pharmacology and clinical efficacy, Therapeutic Drug Monitoring, 5, 199, 10.1097/00007691-198306000-00001 Steinberg, 1977, Penetration of cefamandole into spinal fluid, Antimicrob Agents Chemother, 11, 933, 10.1128/AAC.11.6.933 Steinberg, 1978, Failure of cefamandole in treatment of meningitis due to H. influenzae type B, J Infect Dis, 157, 180, 10.1093/infdis/137.Supplement.S180 Wang, 1985, Efficacy and safety of imipenem/cilastatin: A review of worldwide clinical experience, Rev Infect Dis, 7, 528, 10.1093/clinids/7.Supplement_3.S528 Wiedemann, 1991, Microbiological evaluation of cefpodoxime proxetil, Drugs, 42, S6, 10.2165/00003495-199100423-00004